| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| AstraZeneca is making significant strides in product development, particularly with the recent approval of the SAPHNELO autoinjector for systemic lupus erythematosus and continued innovation in oncology, which emphasizes its strong revenue generation in cancer treatments. The product pipeline is promising, with multiple upcoming Phase III readouts suggesting a positive outlook for future offerings. However, the company faces challenges, including setbacks in drug development and mixed success within its oncology portfolio. Despite these hurdles, AstraZeneca remains committed to refining its pipeline and engaging with regulators to advance its drug development plans. |
| The price action of AstraZeneca (AZN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -2 is very bearish. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for AZN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.7, and the negative at -0.4 on 2026-05-01. The forces of Stock Price Trend (-2), and Valuation Sentiment (-0.2) will drive down the price. The forces of Sector Price Trend (0.1), Price Level Sentiment (0.5), Sentiment towards Fundamentals (1), Market Risk Appetite (1), and Option Sentiment (1.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| AZN | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | 0%(0%) | 184.91 | 3.93% | 9 | -1.36% | -1.04% | -2 | -0.3 | 1.1% | 0.3 | Short | 55% | 1 | -7 |
| 2026-04-30 | 0%(0%) | 187.46 | 3.66% | 13 | 1.17% | -0.67% | -1.6 | 0.1 | 1.1% | 0.4 | Short | 65% | 2 | -8 |
| 2026-04-29 | 0%(0%) | 185.29 | 3.49% | -1 | -0.77% | -0.82% | -2.1 | 0 | 0.8% | 0.1 | Short | 70% | 2.1 | -1 |
| 2026-04-28 | 0%(0%) | 186.73 | 3.07% | -3 | -0.41% | -0.91% | -2 | -0.2 | 0.7% | -0.1 | Short | 70% | 0.6 | 4 |
| 2026-04-27 | 0%(0%) | 187.49 | 2.76% | -7 | -1.15% | -0.75% | -2.3 | -0.5 | 0.9% | -0.2 | Short | 70% | 0.3 | -1 |
| 2026-04-26 | 0%(0%) | -2 | -0.5 | -0.6 | 0.3 | -1 | ||||||||
| 2026-04-25 | 0%(0%) | -2 | -0.5 | -0.6 | 0.3 | -1 | ||||||||
| 2026-04-24 | 0%(0%) | 189.68 | 2.69% | 2 | -1.4% | -0.7% | -2 | -0.2 | 1.5% | -0.6 | Short | 70% | -0.2 | -1 |
| 2026-04-23 | 0%(0%) | 192.38 | 3.04% | 22 | -1.28% | -0.65% | -1.4 | -0.7 | 0.7% | -0.1 | Short | 55% | 0.5 | -1 |
| 2026-04-22 | 0%(0%) | 194.87 | 3.2% | 34 | -0.46% | -0.44% | -0.8 | -0.4 | 1.1% | 0.5 | Short | 55% | 1.4 | -1 |
| Short is the preferred trading strategy with 55% chance of being right. Weak trend sentiment and negative hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| 2026-05-01 17:19:03 Despite setbacks, AstraZeneca’s commitment to continuing discussions and reviews with regulators about its breast cancer therapy shows a proactive approach to future drug development. |
| 2026-05-01 17:19:03 The reactions from the market, as shown by stock drops after FDA panel decisions, indicate a trend where regulatory decisions heavily influence investor sentiment and stock valuations. |
| 2026-05-01 17:19:03 AstraZeneca's varied success with its oncology portfolio, including a positive recommendation for its prostate cancer drug, points to ongoing development efforts despite setbacks. |
| 2026-05-01 17:19:03 The decline in AstraZeneca's stock prices following unfavorable decisions by the FDA significantly reflects the market's reaction to regulatory outcomes. |
| 2026-05-01 17:19:03 The recent votes from the FDA advisory panel against AstraZeneca's breast cancer drug highlight the challenges faced in regulatory approvals and their negative impact on stock performance. |
| 2026-05-01 09:35:18 The implications of clinical trial results on the development of new cancer drugs, reflecting broader issues in pharmaceutical research. |
| 2026-05-01 09:35:18 The negative impact on AstraZeneca's stock following the FDA panel's decision. |
| 2026-05-01 09:35:18 The challenge of meeting regulatory approvals, as seen with AstraZeneca's FDA panel vote impacting stock performance. |